JUN and breast cancer: Western blot analysis demonstrated a significant reduction in the expression levels of phosphorylated JNK (p-JNK, at Thr183/Tyr185) and phosphorylated c-Jun (p-c-Jun, at Ser63) in breast cancer cells that overexpressed miR-17-5p.